Latest Articles

30. 06. 2021

List of reimbursed medicinal products valid as of 1.7.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

10. 06. 2021

Information for marketing authorisation holders concerning the declaration of general classification for supply on medicinal product labelling

SÚKL hereby informs marketing authorisation holders on possible ways of showing the general classification for supply on medicinal product labelling.

 

10. 06. 2021

Information for marketing authorisation holders concerning ways of introducing blue-box information on medicinal product labelling

SÚKL hereby informs marketing authorisation holders about an update to the guidance laying down blue-box requirements for medicinal product labelling.

 

31. 05. 2021

List of reimbursed medicinal products valid as of 1.6.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

30. 04. 2021

List of reimbursed medicinal products valid as of 1.5.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

08. 04. 2021

Correction of the List of reimbursed medicinal products valid as of 8.4.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...